Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodistribution and Pharmacokinetics of [18F]-C-SNAT4 in Healthy Volunteers and Lung Cancer Patients
NCT04017819Phase 1Suspended
- Sponsor
- Stanford University
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- DI (Diagnostic Imaging)
- Countries
- 1
01
Overview
Phase 1, open-label trial of 18F-C-SNAT4 in lung cancer (3 arms), sponsored by Stanford University. Primary endpoint: Biodistribution of [18F]-C-SNAT4 at 1 day. Started Mar 2024; status: suspended.
02
Drugs
18F-C-SNAT4
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT04017819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017819.